PIK3R1 and cholangiocarcinoma: Furthermore, in HuH28 human cholangiocarcinoma cells' research, Okamoto and colleagues found miR-221 could target phosphoinositide-3-kinase, regulatory subunit 1 (PIK3R1), to inhibit HuH28 cell proliferation and conferred Gem sensitivity [89].